AbbVie Stock Prediction and Forecast [ABBV]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 28 Aug 2025, 03:57 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for AbbVie Stock Prediction and Forecast [ABBV]](https://i.ytimg.com/vi/8jOu0lmoxUw/hqdefault.jpg)
AI-generated source summary
This technical analysis of AbbVie (ABBV), published on August 27, 2025, identifies a robust short-term upward trend, estimating an 11.13% change over the upcoming three months with returns ranging from 3.58% to 13.2%. Long-term 12-month outlook predicts approximately 3.08% price appreciation with fluctuations between -15.74% and 8.88%, projecting a future price range of $175.31 to $226.53. The latest daily update on August 27, 2025, shows ABBV's stock price decreasing by 0.144%, fluctuating by 1.26% between a low of $207.81 and a high of $210.42, with a 3 million share volume. Our systems indicate undervaluation and ABBV as a 'Buy Candidate' with signals suggesting further declines until a new bottom pivot is found, a stop loss is suggested at $199.92. It emphasizes the significance of monitoring the upcoming earnings report for the third quarter of 2025.The report notes a recent insider purchase of 42,370 shares and a subsequent insider sale of the same amount.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.